These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1751 related articles for article (PubMed ID: 17978289)
1. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. Sakuramoto S; Sasako M; Yamaguchi T; Kinoshita T; Fujii M; Nashimoto A; Furukawa H; Nakajima T; Ohashi Y; Imamura H; Higashino M; Yamamura Y; Kurita A; Arai K; N Engl J Med; 2007 Nov; 357(18):1810-20. PubMed ID: 17978289 [TBL] [Abstract][Full Text] [Related]
2. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. Sasako M; Sakuramoto S; Katai H; Kinoshita T; Furukawa H; Yamaguchi T; Nashimoto A; Fujii M; Nakajima T; Ohashi Y J Clin Oncol; 2011 Nov; 29(33):4387-93. PubMed ID: 22010012 [TBL] [Abstract][Full Text] [Related]
3. Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer. Jeong JH; Ryu MH; Ryoo BY; Lee SS; Park I; Lee SH; Kim KC; Yook JH; Oh ST; Kim BS; Kang YK Cancer Chemother Pharmacol; 2012 Oct; 70(4):523-9. PubMed ID: 22864947 [TBL] [Abstract][Full Text] [Related]
4. Feasibility study of S-1 for resectable gastric cancer with peritoneal seeding. Fujitani K; Tsujinaka T; Hirao M Hepatogastroenterology; 2003; 50(51):889-92. PubMed ID: 12828112 [TBL] [Abstract][Full Text] [Related]
5. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer. Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256 [TBL] [Abstract][Full Text] [Related]
6. Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases. Inoue T; Yachida S; Usuki H; Kimura T; Hagiike M; Okano K; Suzuki Y Ann Surg Oncol; 2012 Sep; 19(9):2937-45. PubMed ID: 22466666 [TBL] [Abstract][Full Text] [Related]
7. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Koizumi W; Narahara H; Hara T; Takagane A; Akiya T; Takagi M; Miyashita K; Nishizaki T; Kobayashi O; Takiyama W; Toh Y; Nagaie T; Takagi S; Yamamura Y; Yanaoka K; Orita H; Takeuchi M Lancet Oncol; 2008 Mar; 9(3):215-21. PubMed ID: 18282805 [TBL] [Abstract][Full Text] [Related]
8. [Clinical study of S-1 for advanced gastric cancer after reduction surgery]. Inaba Y; Hayashi K; Miura T; Moriya T; Takiguchi M; Isobe H; Watabe S Gan To Kagaku Ryoho; 2007 Jul; 34(7):1053-7. PubMed ID: 17637541 [TBL] [Abstract][Full Text] [Related]
9. [Examination of s-1 therapy for adjuvant chemotherapy in patients with advanced gastric cancer]. Matsui K; Nashimoto A; Yabusaki H; Nakagawa S; Nomura T; Takii Y; Tsuchiya Y; Tanaka O Gan To Kagaku Ryoho; 2009 Jun; 36(6):953-7. PubMed ID: 19542714 [TBL] [Abstract][Full Text] [Related]
10. A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates. Tsuchiya T; Nagayasu T; Yamasaki N; Matsumoto K; Miyazaki T; Tagawa T; Nakamura A; Minami H; Taniguchi H; Akamine S; Hisano H; Taniguchi Y Clin Lung Cancer; 2012 Nov; 13(6):464-9. PubMed ID: 22424872 [TBL] [Abstract][Full Text] [Related]
11. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy]. Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253 [TBL] [Abstract][Full Text] [Related]
12. Factors predictive of recurrence after surgery for gastric cancer followed by adjuvant S-1 chemotherapy. Wada T; Kunisaki C; Hasegawa S; Takagawa R; Momiyama M; Kosaka T; Makino H; Ono HA; Oshima T; Akiyama H; Endo I Anticancer Res; 2013 Apr; 33(4):1747-51. PubMed ID: 23564827 [TBL] [Abstract][Full Text] [Related]
13. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial. Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805 [TBL] [Abstract][Full Text] [Related]
14. Effect of S-1 adjuvant chemotherapy on survival following recurrence and efficacy of first-line treatment in recurrent gastric cancer. Hasegawa H; Fujitani K; Kurokawa Y; Hirao M; Nakazuru S; Mita E; Tsujinaka T Chemotherapy; 2010; 56(6):436-43. PubMed ID: 21088394 [TBL] [Abstract][Full Text] [Related]
15. Phase II study of S-1 monotherapy as a first-line treatment for elderly patients with advanced nonsmall-cell lung cancer: the Central Japan Lung Study Group trial 0404. Nishiyama O; Taniguchi H; Kondoh Y; Takada K; Baba K; Saito H; Sugino Y; Yamamoto M; Ogasawara T; Kondo M; Imaizumi K; Hasegawa Y; Suzuki R; Shimokata K; Anticancer Drugs; 2011 Sep; 22(8):811-6. PubMed ID: 21317767 [TBL] [Abstract][Full Text] [Related]
16. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S; J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327 [TBL] [Abstract][Full Text] [Related]
17. [Examination of continuity of S-1 adjuvant chemotherapy for gastric cancer patients after gastrectomy]. Kawabata R; Imamura H; Kishimoto T; Anami S; Yasui Y; Fujino M; Fujii C; Sumida R; Furukawa H Gan To Kagaku Ryoho; 2011 May; 38(5):793-5. PubMed ID: 21566439 [TBL] [Abstract][Full Text] [Related]
18. [Alternate-day oral therapy with S-1 for adjuvant chemotherapy of gastric cancer]. Takebayashi K; Kawai Y; Tagi T; Matsumura M; Shimizu K; Yamamoto H; Mekata E; Tani T; Sato M Gan To Kagaku Ryoho; 2012 Mar; 39(3):385-7. PubMed ID: 22421764 [TBL] [Abstract][Full Text] [Related]
19. [The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer]. Sugimoto N; Narahara H; Sakai D; Yamamoto S; Fumoto S; Yagi T; Imamura F; Iishi H; Tatsuta M Gan To Kagaku Ryoho; 2009 Mar; 36(3):417-24. PubMed ID: 19295265 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma. Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]